MFIM
ABOS icon

Mesirow Financial Investment Management’s Acumen Pharmaceuticals ABOS Stock Holding History

Mesirow Financial Investment Management’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.2K Hold
11,305
– – ﹤0.01% 527
2026
Q1 		$26.7K Buy
+11,305
New +$28.8K ﹤0.01% 517

Other funds holding ABOS

PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CA
Clune & Associates Chicago, Illinois $661M AUM 21.51% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $902M AUM 21.74% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Mesirow Financial Investment Management's ABOS Position: Q2 2026 in Review

Mesirow Financial Investment Management held its Acumen Pharmaceuticals (ABOS) position steady in Q2 2026 at 11,305 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #527.

Mesirow Financial Investment Management first reported a position in ABOS in Q1 2026 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • Mesirow Financial Investment Management held 11,305 shares of Acumen Pharmaceuticals worth $30.2K as of Q2 2026.
  • Mesirow Financial Investment Management left its Acumen Pharmaceuticals share count unchanged in Q2 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #527 holding.
  • Mesirow Financial Investment Management first reported a position in Acumen Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 9 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.